- Discovery of novel 7-azaindole derivatives bearing dihydropyridazine moiety as c-Met kinase inhibitors.
Discovery of novel 7-azaindole derivatives bearing dihydropyridazine moiety as c-Met kinase inhibitors.
European journal of medicinal chemistry (2017-04-07)
Qidong Tang, Linxiao Wang, Yongli Duan, Wenhui Wang, Shunmin Huang, Jia Zhi, Shuang Jia, Wufu Zhu, Ping Wang, Rong Luo, Pengwu Zheng
PMID28384549
ABSTRACT
A series of 7-azaindole derivatives bearing the dihydropyridazine scaffold were synthesized and evaluated for their c-Met kinase inhibitory, and antiproliferative activity against 4 cancer cell lines (HT29, A549, H460, U87MG) were evaluated in vitro. Most compounds showed moderate to excellent potency. Compared to foretinib, the most promising analog 34 (c-Met IC
MATERIALS
Product Number
Brand
Product Description